Research

Micronutrients & recovery

GLP-1 receptor agonist (GLP-1RA) therapy is associated with clinically relevant risks of protein, vitamin, and mineral deficiencies due to reduced caloric and nutrient intake.

If you are taking a GLP-1 medication like semaglutide or tirzepatide, you are likely eating less, which means you might not be getting enough vitamins and minerals. You should prioritize nutrient-dense foods and discuss baseline blood testing for Vitamin D, B12, Iron, and Calcium with your doctor. Do not assume that because this is a medication and not surgery, you are exempt from nutritional monitoring.

ModerateSupportsMEDIUM confidence
GLP-1RAs are associated with clinically relevant risks of protein, vitamin, and mineral deficiencies.
Rhea Sibal et al. · Nutrients · 2025

Why this rating

Based on a narrative review of observational studies, retrospective cohorts, and some RCTs, but lacking large-scale long-term RCTs on supplementation outcomes.

Source

Macronutrient, Micronutrient Supplementation and Monitoring for Patients on GLP-1 Agonists: Can We Learn from Metabolic and Bariatric Surgery?

Rhea Sibal et al. · Nutrients · 2025

narrative_reviewCited 9×
Read the paper

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →